Home >> Research Area >>Apoptosis>>p53>> RETRA hydrochloride

RETRA hydrochloride

Antitumor agent CAS# 1036069-26-7

RETRA hydrochloride

Catalog No. BCC2415----Order now to get a substantial discount!

Product Name & Size Price Stock
RETRA hydrochloride: 5mg $92 In Stock
RETRA hydrochloride: 10mg Please Inquire In Stock
RETRA hydrochloride: 20mg Please Inquire Please Inquire
RETRA hydrochloride: 50mg Please Inquire Please Inquire
RETRA hydrochloride: 100mg Please Inquire Please Inquire
RETRA hydrochloride: 200mg Please Inquire Please Inquire
RETRA hydrochloride: 500mg Please Inquire Please Inquire
RETRA hydrochloride: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of RETRA hydrochloride

Number of papers citing our products

Chemical structure

RETRA hydrochloride

3D structure

Chemical Properties of RETRA hydrochloride

Cas No. 1036069-26-7 SDF Download SDF
PubChem ID 46861546 Appearance Powder
Formula C11N11NO3S2 M.Wt 412.3
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble in DMSO > 10 mM
Chemical Name 2-(4,5-dihydro-1,3-thiazol-2-ylsulfanyl)-1-(3,4-dihydroxyphenyl)ethanone;hydrochloride
SMILES C1CSC(=N1)SCC(=O)C2=CC(=C(C=C2)O)O.Cl
Standard InChIKey ZZAVDVMJZKDBIB-UHFFFAOYSA-N
Standard InChI InChI=1S/C11H11NO3S2.ClH/c13-8-2-1-7(5-9(8)14)10(15)6-17-11-12-3-4-16-11;/h1-2,5,13-14H,3-4,6H2;1H
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

RETRA hydrochloride Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

RETRA hydrochloride Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of RETRA hydrochloride

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.4254 mL 12.1271 mL 24.2542 mL 48.5084 mL 60.6355 mL
5 mM 0.4851 mL 2.4254 mL 4.8508 mL 9.7017 mL 12.1271 mL
10 mM 0.2425 mL 1.2127 mL 2.4254 mL 4.8508 mL 6.0635 mL
50 mM 0.0485 mL 0.2425 mL 0.4851 mL 0.9702 mL 1.2127 mL
100 mM 0.0243 mL 0.1213 mL 0.2425 mL 0.4851 mL 0.6064 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on RETRA hydrochloride

IC50: Inhibit tumor cells growth with an IC50of about 4 M.

Being defective for the tumor-suppressor function, mutant p53, a major contributor to malignancy, exerts oncogenic activity also by blocking another tumor-suppressing protein - p73. RETRA hydrochloride is considered to restore mutant p53 activity and therefore to inhibit growth of carcinoma cells. This small molecular could also transcriptionally up-regulates the expression of p53-responsive gene and induces the activation of caspases 3 and 7. RETRA’s anticancer activity is restricted to tumor cells bearing mutant p53. [1]

In vitro: Ewing’s sarcoma (ES) cells with mutant p53 were explored to RETRA, it was found that this compound could substantially up-regulate the expression level of p73 and therefore increase the apoptosis of tumor cells in three mutant p53 ES cell lines. In addition, RETRA was described to activate a set of p53-regulated genes in vitro. However, for most of the p53-deficient carcinoma, osteosarcoma and leukaemia cells, RETRA had no significant effect. [1, 2]

In vivo: Effect of RETRA hydrochloride was studied in vivo using mouse xenografts model. It was noticed that mutant p53-bearing tumor cells were specifically suppressed with a significantly increase in the p73 level and a release of p73 from the blocking complex with mutant p53. [1]

Clinical trial: So far, no clinical study has been conducted.

References:
[1] Kravchenko JE, Ilyinskaya GV, Komarov PG, Agapova LS, Kochetkov DV, Strom E, Frolova EI, Kovriga I, Gudkov AV, Feinstein E, Chumakov PM.  Small molecular RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway. PNAS. 2008 Apr; 105(17): 6302–7.
[2] Sonnemann J, Grauel D, Blumel L, Hentschel J, Marx C, Blumrich A, Focke K, Becker S, Wittig S, Schinkel S, Kramer OH, Beck JF.  RETRA exerts anticancer activity in Ewing’s sarcoma cells independent of their TP53 status. EUR J CANCER. 2015 Feb; 51:841-851.

Featured Products
New Products
 

Keywords:

RETRA hydrochloride,1036069-26-7,Natural Products,p53, buy RETRA hydrochloride , RETRA hydrochloride supplier , purchase RETRA hydrochloride , RETRA hydrochloride cost , RETRA hydrochloride manufacturer , order RETRA hydrochloride , high purity RETRA hydrochloride

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: